**Interaction of Alkylphospholipid Formulations with Breast Cancer Cells in the Context of Anticancer Drug Development**

Tilen Koklic1,2, Rok Podlipec1,2, Janez Mravljak3, Maja Garvas1, Marjeta Šentjurc1 and Reiner Zeisig4 *1Jozef Stefan Institute, Ljubljana 2Center of Excellence NAMASTE, Ljubljana 3Faculty of Pharmacy, University of Ljubljana, Ljubljana 4Max-Delbrück-Centre for Molecular Medicine, Berlin-Buch, 1,2,3Slovenia 4Germany* 
